Kim Hyung-Sook, Park Se Yoon, Choi Heun, Park Ji Young, Lee Mi Suk, Eun Byung Wook, Lee Hyukmin, Choi Jun Yong, Kim Hong Bin, Jeong Su Jin, Uh Young, Kim Bongyoung
Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Korea.
Korean Society of Health-System Pharmacist, Seoul, Korea.
Infect Chemother. 2022 Sep;54(3):483-492. doi: 10.3947/ic.2022.0107.
It is necessary to develop a roadmap for antimicrobial usage monitoring in order to perform monitoring of antimicrobial use at the national level properly. Therefore, this study aimed to develop a roadmap for establishing surveillance and monitoring of antimicrobial use in medical institutions at the national level.
A modified Delphi study was conducted, including 3 rounds of an online survey and a virtual meeting with 16 expert panels. The survey items were developed based on a literature review of the surveillance systems for antimicrobial use in 12 countries and interviews with experts. The questionnaire was designed to include both the surveillance and benchmarking systems.
Regarding the scope of target institutions to be included in the surveillance system, medical institutions for sentinel surveillance had the highest proportion of agreement among the panels (75.0%, 9/12). For the benchmarking system, "tertiary- and secondary-care hospitals" were accepted as the scope of target institutions at the current moment. Furthermore, the National Health Insurance claims and prescription data of individual hospitals were considered appropriate data sources for the surveillance system. As for the measures to promote the participation of hospitals in the benchmarking system, "compensation through the establishment of antimicrobial management fees" and "set the participation in the program as a quality evaluation or accreditation index for hospital evaluation" were accepted.
This study provides a roadmap for establishing an antimicrobial use monitoring and benchmarking system for medical institutions at a national level in Korea.
有必要制定抗菌药物使用监测路线图，以便在国家层面妥善开展抗菌药物使用监测。因此，本研究旨在制定一份路线图，用于在国家层面建立医疗机构抗菌药物使用监测体系。
开展了一项改良的德尔菲研究，包括三轮在线调查以及与16个专家小组进行的一次虚拟会议。调查项目是基于对12个国家抗菌药物使用监测系统的文献综述以及对专家的访谈而制定的。调查问卷旨在涵盖监测和基准系统。
关于监测系统中纳入的目标机构范围，哨点监测医疗机构在各小组中获得同意的比例最高（75.0%，9/12）。对于基准系统，目前“三级和二级医疗机构”被接受为目标机构范围。此外，国家健康保险理赔数据和各医院的处方数据被认为是监测系统的合适数据来源。至于促进医院参与基准系统的措施，“通过设立抗菌药物管理费用进行补偿”以及“将参与该项目设定为医院评估的质量评估或认证指标”获得认可。
本研究为韩国在国家层面建立医疗机构抗菌药物使用监测和基准系统提供了路线图。
